- TWD14.13bn
- TWD24.57bn
- TWD7.20bn
- 15
- 30
- 55
- 20
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,469 | 4,667 | 6,077 | 7,741 | 7,200 |
Cost of Revenue | |||||
Gross Profit | 612 | 943 | 1,409 | 2,099 | 1,836 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,461 | 4,488 | 5,655 | 6,493 | 6,451 |
Operating Profit | 7.33 | 179 | 422 | 1,248 | 749 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 375 | 631 | 1,139 | 674 | 446 |
Provision for Income Taxes | |||||
Net Income After Taxes | 312 | 486 | 847 | 446 | 164 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 431 | 684 | 1,147 | 704 | 366 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 431 | 684 | 1,153 | 718 | 380 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.17 | 3.91 | 5.42 | 3.11 | 1.57 |
Dividends per Share |